I
Ilya Pharma
Biotech & Life Sciences · Uppsala kommun, Sweden · Founded 2016
Ilya Pharma develops immune-cell therapies. The company's biological medicine uses lactic acid bacteria as vectors to deliver biological drugs on-site to skin wounds or the GI tract MoreLess
Developer of next-generation biological drugs designed to treat wounds in skin and mucosa. The company's biological drug is a novel drug delivery system where lactic acid bacteria are used as vectors to produce and deliver biological drugs on-site to skin wounds or in the gastrointestinal tract, its human therapeutic proteins are delivered on-site in wounds by living lactic acid bacteria acting like small bioreactors, enabling patients with diabetes to get accelerated healing of a chronic wound in a cost-effective way. Keywords: Pharmaceuticals and BiotechnologyBiological Drug Developer, Biological Drugs, Biological Drugs Developer, Healthcare Delivery, Human Therapeutic Protein, Local Immunotherapy, Local-Acting Immunotherapy, Wound Healing Drugs, Wound Treatment.
Talent graph
Ilya Pharma's talent
Source: Dealroom Talent Intelligence.
Investors
3 investors on Ilya Pharma's cap table
Sourced from Dealroom's funding and investor records.
Global footprint
Where Ilya Pharma has talent and traffic
team presence
Market sentiment
What the market is saying about Ilya Pharma
An AI-synthesized read of the highest-engagement posts about Ilya Pharma on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Ilya Pharma on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.